Details of a clinical trial for PR positive advanced/recurrent endometrial andnorcarcinoma and low grade endometrial stromal sarcoma - get the details via the link copied below if you qualify:
Mifepristone for Patients With Endometrial Cancer and LGESS
This study is currently recruiting participants.
Verified by M.D. Anderson Cancer Center, July 2007
Phase II Study of Mifepristone (RU-486) in the Treatment of PR Positive Advanced/Recurrent Endometrioid Adenocarcinoma and Low Grade Endometrial Stromal Sarcoma (LGESS)